AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Red Light Therapy: Short-term Choroidal and Retinal Changes

RecruitingNAAges 18 Years - 40 YearsAllThe Hong Kong Polytechnic University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This research project is a prospective, randomized controlled trial designed to assess the short-term effects of varied red light therapies on the choroidal and retinal structures in adult myopes. The primary objective is to determine which specific retinal regions or cells are primarily affected by short-term repeated low-level red-light (RLRL) therapy, potentially inducing choroidal thickening. The secondary objective is to assess the safety of different types of red light therapy in adult myopes. The study will enroll 45 myopic adults aged 18-40 years old as participates. They will be randomly assigned into three RLRL groups: small circle (d=0.30mm), medium circle (d=0.50mm), and annular groups (an inner diameter of 0.50 mm and an outer diameter of 0.70mm) without disclosure of their specific group to maintain study blinding. The groups are differentiated by the size and shape of the

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age: 18 to 40 years. 2. Myopic spherical equivalent refraction (SER) between -1.00D to -6.00D in both eyes. 3. Best corrected visual acuity (BCVA): 20/20 or greater. 4. Informed consent for participation. Exclusion Criteria: 1. Anisometropia greater than 1.50D. 2. Ophthalmic diseases other than refractive errors, including but not limited to strabismus and binocular vision abnormalities in either eye. 3. Systemic diseases (e.g., endocrine, cardiac diseases) and developmental abnormalities. 4. Inability to attend regular follow up assessment. 5. Undergo RLRL therapy in the past 6 months 6. Contraindications to RLRL therapy.
๐Ÿ’Š

What it tests

  • Repeated Low-Level Red-Light
๐Ÿ“

Where

1 site
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy